发明授权
- 专利标题： MAPK inhibition by H2
- 专利标题（中）： H2抑制MAPK
-
申请号： US13820209申请日： 2011-09-02
-
公开(公告)号： US08992998B2公开(公告)日： 2015-03-31
- 发明人: Toshihisa Kawai , Mikihito Kajiya , Kimihiro Sato
- 申请人： Toshihisa Kawai , Mikihito Kajiya , Kimihiro Sato
- 代理机构： Kohn & Associates PLLC
- 国际申请： PCT/US2011/050310 WO 20110902
- 国际公布： WO2012/031189 WO 20120308
- 主分类号： A01N59/00
- IPC分类号： A01N59/00 ; A23L2/52 ; A61K33/00 ; C25B1/04
摘要：
A method of treating inflammation in a subject by administering a composition including hydrogen, releasing hydrogen in the subject, suppressing mitogen-activated protein kinase (MAPK) phosphorylation and upregulating expression of MKP-1, and down-regulating inflammatory responses of monocyte lineage cells.
公开/授权文献
- US20130266540A1 MAPK INHIBITION BY H2 公开/授权日：2013-10-10
信息查询
